Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology

ORCID: 0000-0002-9451-6037

Publication year:
All
1 - 6 out of 6Page size: 10
  1. 2023
  2. Published

    ASO Visual Abstract: Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma-A National Cohort Study of 1480 Patients

    Helvind, N. M., Weitemeyer, M. B. M., Chakera, A. H., Hendel, Helle Westergren, Ellebæk, E., Svane, Inge Marie, Kjærskov, M. W., Bojesen, S., Skyum, H., Petersen, S. K., Bastholt, L., Johansen, Christoffer, Bidstrup, P. E. & Hølmich, Lisbet Rosenkrantz, 2023, In: Annals of Surgical Oncology. 30, 4, p. 2389-2390 2 p.

    Research output: Contribution to journal › Conference abstract in journal › Research

  3. 2019
  4. Published

    Assessment of extracellular matrix and tissue derived metabolites in a liquid biopsy for identifying endotypes of metastatic melanoma patients with differential response to immune checkpoint inhibitor treatment.

    Willumsen, N., Bager, C. L., Jensen, C., Karsdal, M. A., Madsen, Daniel Hargbøl, Hansen, M., Schmidt, H. & Svane, Inge Marie, 2019, In: Journal of Clinical Oncology. 37, 15_suppl, e14050.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  5. 2012
  6. Published

    IFN-γ to improve immunotherapy for melanoma

    Donia, M., Svane, Inge Marie, Andersen, M. H., Hansen, M., Straten, P. T., Ellebæk, E., Iversen, T. Z. & SL, S., 2012. 0 p.

    Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

  7. 2010
  8. Published

    Combined Treatment with Dendritic Cell Vaccine and Low-Dose Cyclophosphamide in Patients with Malignant Melanoma

    Engell-Noerregaard, L., Ellebaek, E., Buch-Hansen, T. Z., Nikolajsen, K., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876-877 2 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  9. Published

    Dendritic Cells Transfected with mRNA for p53, Survivin and hTERT as Treatment for Patients With Malignant Melanoma or Breast Cancer-A Phase I Study

    Engell-Noerregaard, L., Hansen, T. H., Met, Ö., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  10. Published

    Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial

    Buch-Hansen, T. Z., Sørensen, R. B., Mellemgaard, A., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 919-920 2 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

ID: 4054758